Shoulder Innovations (FRA:VB3) EPS without NRI: €-1.41 (TTM As of Mar. 2026)


FRA:VB3 Shoulder Innovations Inc FRA:VB3
18 GF Score
Price €18.70
! 6 Warning Signs
View Full Analysis

What is Shoulder Innovations EPS without NRI?

Shoulder Innovations FRA:VB3 +8.72% 18 EPS without NRI is €-1.41 as of Mar. 2026. GuruFocus rates FRA:VB3 with a GF Score™ of 18/100. The stock has 6 warning signs investors should review. Among 667 Medical Devices & Instruments companies, Shoulder Innovations ranks worse than 149924.89% on this metric.

Shoulder Innovations's earnings per share without non-recurring items for the three months ended in Mar. 2026 was €-0.36. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was €-1.41.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Shoulder Innovations's EPS without NRI or its related term are showing as below:

FRA:VB3's 3-Year EPS without NRI Growth Rate is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 8.1
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

Shoulder Innovations's EPS (Diluted) for the three months ended in Mar. 2026 was €-0.36. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €-2.05.

Shoulder Innovations's EPS (Basic) for the three months ended in Mar. 2026 was €-0.36. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was €-2.05.


Shoulder Innovations  (FRA:VB3) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Shoulder Innovations EPS without NRI Related Terms


Shoulder Innovations EPS without NRI Historical Data

* Premium members only.

The historical data trend for Shoulder Innovations's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shoulder Innovations EPS without NRI Chart

Shoulder Innovations Annual Data
Trend Dec23 Dec24 Dec25
EPS without NRI
-0.52 -0.74 -2.60

Shoulder Innovations Quarterly Data
Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.21 -0.32 -0.41 -0.33 -0.36

FRA:VB3 vs ELMD, MASS, CV: EPS without NRI Comparison

For the Medical Devices subindustry, Shoulder Innovations's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shoulder Innovations PE Ratio without NRI vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shoulder Innovations's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Shoulder Innovations's PE Ratio without NRI falls into.


FRA:VB3
18GF Score
Shoulder Innovations Inc FRA:VB3
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shoulder Innovations EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of €-1.41 mean?
Shoulder Innovations (FRA:VB3) has a EPS without NRI of €-1.41 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Shoulder Innovations and its competitors. According to the industry distribution chart, Shoulder Innovations ranks #999999 out of 667 companies in the Medical Devices & Instruments industry.
Is Shoulder Innovations' EPS without NRI too high?
Shoulder Innovations' current EPS without NRI is €-1.41. Based on the distribution chart, Shoulder Innovations ranks #999999 out of 667 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Shoulder Innovations has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Shoulder Innovations' EPS without NRI compare to ELMD and MASS?
According to the Medical Devices & Instruments industry distribution chart, Shoulder Innovations ranks #999999 out of 667 companies for EPS without NRI. This places Shoulder Innovations in the lower half of its industry. The industry median EPS without NRI is 8.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Devices & Instruments company?
The median EPS without NRI among Medical Devices & Instruments companies is 8.10, based on 667 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Shoulder Innovations and its competitors. For the Medical Devices & Instruments industry, the median EPS without NRI is 8.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shoulder Innovations's current EPS without NRI is €-1.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shoulder Innovations stock overvalued right now?
Shoulder Innovations (FRA:VB3) has a current EPS without NRI of €-1.41. The current EPS without NRI is €-1.41. Shoulder Innovations' overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Shoulder Innovations (FRA:VB3), the current EPS without NRI is €-1.41 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Shoulder Innovations Business Description

Other Exchanges SI:USA
Address 1535 Steele Avenue SW, Suite B, Grand Rapids, MI, USA, 49507
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System. Geographically, the company operates in United States and are planning to expand.
18GF Score

Get the complete analysis for FRA:VB3

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€18.70
Price